Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 28, 2025Open Access

Injectable Liposomal Formulations for Sustained Release of Anticancer Drugs

View Full Paper
Ask AI
Bookmark
Share

Authors

DLDeepesh LallGuru Ghasidas VishwavidyalayaAVAkanksha VaishnavWayne State UniversityPRPrakash Kumar Ratre

Discussion

Loading...

Member takes

Overview

Liposomal formulations improve anticancer drug delivery, enhancing efficacy and reducing toxicity in tumors, indicating promising clinical potential.

Key Points

  • Enhanced drug delivery leads to increased therapeutic efficacy and reduced systemic toxicity, improving patient outcomes.
  • Liposomal encapsulation improved intratumoral drug concentration and safety profile, showing lower cardiotoxicity and nephrotoxicity.
  • Application of the EPR effect allows selective targeting of tumors, improving the effectiveness of anticancer drugs.
  • Ongoing optimization in lipid composition and surface modification highlights the potential for clinical translation of these formulations.

Cite This Study

Lall et al. (2025) studied this question.

synapsesocial.com/papers/68d913a34ddcf71ba560b8d5https://doi.org/10.64063/3049-1681.vol.2.issue9.9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Review on Liposomal Drug Delivery in Cancer Therapy2025
  2. 2Liposomal nanotherapeutics for cancer treatment: Targeted delivery and immunotherapy2026 · 2 citations
  3. 3Liposomal Nanoparticle-Based Drug Delivery System for Enhanced Bioavailability in Anticancer Therapy: A Comprehensive Review2026
  4. 4Liposomal Nanoparticle-Based Drug Delivery System for Enhanced Bioavailability in Anticancer Therapy: A Comprehensive Review2026
  5. 5Advanced Liposomal Systems for Cancer Therapy with Focus on Lipid–Polymer Hybrids and Cell Membrane-Coated Liposomes2026 · 2 citations